5 Grants
2021
Novel Enzyme Inhibitors in the Innate Immune Evasion Repertoire of Staphylococci
GEISBRECHT, BRIAN V
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 1R35GM140852-01), $363,312USD, 2021-05-01 -- 2026-02-28
 
Structure/Function Studies of LILRs Enabled by a Bacterially-Derived Ligand
GEISBRECHT, BRIAN V
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 1R21AI155828-01), $190,000USD, 2020-11-25 -- 2022-10-31
2016
Inhibition of the Classical & Lectin Complement Pathways by Staphylococcus aureus Eap
GEISBRECHT, BRIAN V
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5R21AI111203-02), $187,500USD, 01/01/2015 -- 12/31/2016
2015
Inhibition of the Classical &Lectin Complement Pathways by Staphylococcus aureus Eap
GEISBRECHT, BRIAN V
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 1R21AI111203-01A1), $187,500USD, 01/01/2015 -- 12/31/2017
2008
Structure Function Analysis of Staphylococcal Complement Inhibitors
GEISBRECHT, BRIAN
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 1R01AI071028-01A2), $318,750USD, 02/01/2008 -- 01/31/2013